Surveying cranberry effect on urinary tract infection in childre
Phase 2
Completed
- Conditions
- Recurrent urinary tract infection.Urinary tract infection, site not specifiedN39.0
- Registration Number
- IRCT20191207045640N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
All children with recurrent urinary tract infection
Written parental consent
Exclusion Criteria
Children under the age of one month
Parental dissatisfaction
Patients who are unable to use the medication in question due to the patient's departure from the usual route to complication or deterioration
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cranberry's anti-adhesive effects against uropathogenic E. coli in pediatric UTIs?
How does cranberry compare to nitrofurantoin in preventing recurrent UTIs in children: efficacy and safety profiles?
Which urinary biomarkers (e.g., uroplakin, cytokines) correlate with cranberry response in IRCT20191207045640N1?
What adverse events are reported in IRCT20191207045640N1 cranberry vs. antibiotic trials for pediatric UTIs?
Are there synergistic effects of cranberry with probiotics or other phytochemicals in UTI prevention strategies?